| SESSION 9: MEDICAL ISSUES ASSOCIATED WITH
CONTRACEPTION |
 |
||
| nr. | title | 1st
author |
abstract |
| P159 | Intrauterine devices and severe pelvic inflammatory disease require hospitalization | V. Kova (Slovenia) | abstract |
| P160 | Pelvic actinomycosis. A comparison of three recent cases with the literature | A. Baird (UK) | abstract |
| P161 | Hormonal contraception in women with diabetes mellitus: a review of the literature | J Shawe (UK) | abstract |
| P162 | Effects of the continuous use of a combination of ethinyl-estradiol/gestodene in the control of
symptoms reported during the hormone-free interval |
R.B. Machado (Brazil) | abstract |
| P163 | Metabolic effects of the continuous use of an oral contraceptive containing ethinyl-estradiol and
gestodene |
R.B. Machado (Brazil) | abstract |
| P164 | Bleeding patterns in users of a continuous contraceptive combination containing ethinyl-estradiol and
gestodene |
R.B. Machado (Brazil) | abstract |
| P165 | Effect of contraception on depression: comparison of Edinburgh and Beck depression scales | K. Ertopçu (Turkey) | abstract |
| P166 | Effect of subdermal contraceptive implant (Implanon1) on biochemical serum parameters | M.Inal (Turkey) | abstract |
| P167 | Effect of subdermal contraceptive implant (Implanon1) on hormonal parameters | M. Inal (Turkey) | abstract |
| P168 | The research of the gonadotropic hormones and prolactin levels in young women while using lowdosed
combined oral contraceptives |
L.V. Suturina (Russia) | abstract |
| P169 | A non-contraceptive use of the levonorgestrel-releasing intrauterine system: management of
endometrial hyperplasia |
Z. Sgarbura (Romania) | abstract |
| P170 | Management of contraception in women post organ transplant on tacrolimus – case report and
literature review |
A. Brockmeyer (UK) | abstract |
| P171 | Evaluation of the SHT470 FA (30 mcg of ethinylestradiol and 3 mg of drospirenone) on contraceptive
efficacy, tolerance, cycle control and effects on general well being and fluid-related symptoms in women seeking contraception and with premenstrual disorders |
A.F. Camargos (Brazil) | abstract |
| P172 | A survey of postnatal contraception in opiate-using women | C. Sinha (UK) | abstract |
| P173 | Treatment of endometriosis with Implanon versus GnRH agonists: effect on insulin sensitivity | A. Cagnacci (Italy) | abstract |
| P174 | Type of progestogen in combined oral contraceptives and risk of myocardial infarction | P. O’Brien (UK) | abstract |
| P175 | Experience with Tri-Merci used for combined therapy of cervical intraepithelial neoplasia in patients
with hyperandrogenia |
A.A. Sukhanova (Ukraine) | abstract |
| P176 | The breast tenderness during using transdermal contraception with evening primrose oil and vitamin E | A. Korenek (Czech Republic) | abstract |
| P177 | Tuboovarian abscess associated with an intrauterine device: report on three cases | A. Pretnar-Darovec (Slovenia) | abstract |
| P178 | Effects of a monthly injectable contraceptive (Cyclofem) on menstrual pattern and lipoprotein profile | F. Ramezani Tehrani (Iran) | abstract |
| P179 | Endometrial morphology and bleeding patterns in Mirena1 users | F. Martinez (Spain) | abstract |
| P180 | The case of the missing implant: the importance of adhering to insertion guidelines | U. Ernst (Germany) | abstract |
|
|||